Molecule Information
General Information of the Molecule (ID: Mol01963)
Name |
Sclerostin (SOST)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
SOST; UNQ2976/PRO7455/PRO7476
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
SOST
|
||||
Gene ID | |||||
Location |
chr17:43,753,738-43,758,791[-]
|
||||
Sequence |
MQLPLALCLVCLLVHTAFRVVEGQGWQAFKNDATEIIPELGEYPEPPPELENNKTMNRAE
NGGRPPHHPFETKDVSEYSCRELHFTRYVTDGPCRSAKPVTELVCSGQCGPARLLPNAIG RGKWWRPSGPDFRCIPDRYRAQRVQLLCPGGEAPRARKVRLVASCKCKRLTRFHNQSELK DFGTEAARPQKGRKPRPRARSAKANQAELENAY Click to Show/Hide
|
||||
Function |
Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Ensembl ID | |||||
HGNC ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Pyrvinium
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Anaplastic thyroid cancer | [1] | |||
Sensitive Disease | Anaplastic thyroid cancer [ICD-11: 2D10.2] | |||
Sensitive Drug | Pyrvinium | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Wnt signaling pathway | Activation | hsa04310 | |
In Vitro Model | LNCaP cells | Prostate | Homo sapiens (Human) | CVCL_0395 |
HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 | |
Experiment for Molecule Alteration |
Western blotting analysis; ART sensitivity assay | |||
Experiment for Drug Resistance |
CCK-8 cell proliferation assay; Flow cytometry | |||
Mechanism Description | Pyrvinium pamoate can overcome artemisinin's resistance in anaplastic thyroid cancer. The resistance of CAL-62 to ART was related to the upregulation of the WNT signaling pathway. |
Disease- and Tissue-specific Abundances of This Molecule
ICD Disease Classification 02
Thyroid cancer [ICD-11: 2D10]
Differential expression of molecule in resistant diseases | ||
The Studied Tissue | Thyroid | |
The Specified Disease | Thyroid cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 7.33E-05; Fold-change: -1.02E-01; Z-score: -1.70E-01 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 6.99E-02; Fold-change: -4.74E-02; Z-score: -1.25E-01 | |
Molecule expression in the normal tissue adjacent to the diseased tissue of patients
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
Disease-specific Molecule Abundances | Click to View the Clearer Original Diagram | |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.